Details of the Drug

General Information of Drug (ID: DMB5KRA)

Drug Name
CFI-402411
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Drug Type
Small molecular drug
Cross-matching ID
TTD ID
DXK49H

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MEK kinase kinase 1 (MAP4K1) TTSHWUP M4K1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04521413) Safety and Efficacy Study Of CFI-402411 in Subjects With Advanced Solid Malignancies. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Treadwell Therapeutics.